ITEMS IN AFP WITH KEYWORD:
In high-risk older patients with recent-onset atrial fibrillation, a strategy of rhythm control results in fewer cardiovascular deaths and fewer strokes.
A lower dose of edoxaban is effective in decreasing stroke and systemic embolism in older patients with atrial fibrillation compared with placebo.
This guideline on atrial fibrillation (AF) management from the American Heart Association (AHA), American College of Cardiology (ACC), and Heart Rhythm Society (HRS) is an update of the 2014 version and is based on new evidence from clinical trials and the U.S. Food and Drug Administration (FDA).
For patients presenting to the emergency department with recent-onset symptomatic atrial fibrillation, early cardioversion is no better than delayed cardioversion in achieving sinus rhythm within four weeks.
Oct 1, 2019 Issue
Effectiveness and Safety of Factor Xa Inhibitors in Patients with Atrial Fibrillation [Cochrane for Clinicians]
Treatment of AFib with a factor Xa inhibitor results in a decrease in the combined end point of stroke and embolic events (odds ratio [OR] = 0.89; 95% CI, 0.82 to 0.97), as well as a decrease in intracranial hemorrhage (OR = 0.50; 95% CI, 0.42 to 0.59) and all-cause mortality (OR = 0.89; 95% CI, 0.8...
Apr 15, 2019 Issue
Bridging Warfarin Before Colonoscopy in Patients with Atrial Fibrillation [FPIN's Clinical Inquiries]
A limited number of trials that examined the risk of temporary interruption of anticoagulation before a variety of procedures did not find a reduction in the risk of stroke, but they did show an increased risk of bleeding events and venous thromboembolism (VTE) in patients who were bridged during warfarin interruption.
Direct oral anticoagulants are as likely as warfarin to prevent all strokes and systemic embolic events in patients with atrial fibrillation and CKD stage 3. They do not increase the risk of major bleeding events. The evidence remains insufficient to make recommendations for the use of direct oral a...
Mar 15, 2019 Issue
Screening for Atrial Fibrillation with Electrocardiography: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for atrial fibrillation with electrocardiography.
Mar 15, 2019 Issue
Screening for Atrial Fibrillation with Electrocardiography [Putting Prevention into Practice]
M.T. is a 67-year-old woman who presents to your office requesting electrocardiography (ECG). Her brother was recently diagnosed with atrial fibrillation after screening with ECG, and she is concerned that she may have the same condition.
Despite the lack of outcomes evidence, the rise of wearable ECG sensors will cause many individuals to seek care for misdiagnosed AF. The best intervention for patients with correct diagnoses remains unclear. Primary care physicians must use their skills in discussing uncertainty and aligning care with patients' goals.